Stryker (SYK) vs Boston Scientific (BSX): Which is a Better Stock to Buy?

insidermonkey.com · 2026-10-07

Stryker Corporation (NYSE:SYK) traded at around $280 on October 6, 22.75% lower over twelve months.

TickrTrends take: Boston Scientific trades at a valuation that TickrTrends currently assesses as undervalued within the Healthcare sector, making it relevant to comparison discussions with peers like Stryker. A valuation-focused reader should monitor whether BSX's current pricing reflects genuine market inefficiency or temporary sector conditions, as direct comparisons between competing medical device companies often help clarify relative value opportunities. The undervalued designation suggests the market may not be fully pricing BSX's operational performance or growth prospects relative to its fundamentals.

Read the full story at insidermonkey.com →